MICHAEL BARNETT: Open Payments
NPI 1760565154 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 27 payments from 5 companies in 2025. Trend: 2023 $503 · 2024 $526 · 2025 $632
Food & beverage: $520Education: $111
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 9 | $277 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $176 |
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Alkermes, Inc. | 2 | $27 |
Products named: HETLIOZ, CAPLYTA, COBENFY, ARISTADA, LYBALVI.
Industry payments across CA — which companies pay providers there.
